2023 Q2 Form 10-Q Financial Statement
#000175337323000009 Filed on April 13, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
Revenue | $3.400K | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | $3.400K | ||
YoY Change | |||
Gross Profit Margin | 100.0% | ||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $444.1K | $31.39K | |
YoY Change | 3377.48% | ||
Operating Profit | -$444.1K | -$27.99K | |
YoY Change | 3377.48% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$114.00 | ||
YoY Change | |||
Pretax Income | -$539.1K | $27.99K | $11.50K |
YoY Change | 4121.93% | 143.38% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$539.1K | -$27.99K | -$11.50K |
YoY Change | 4121.93% | 143.38% | |
Net Earnings / Revenue | -823.26% | ||
Basic Earnings Per Share | -$0.01 | $0.00 | $0.00 |
Diluted Earnings Per Share | -$0.01 | $0.00 | |
COMMON SHARES | |||
Basic Shares Outstanding | 7.105M shares | 7.105M shares | 5.092M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $308.2K | $114.00 | $114.00 |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | $13.57K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $308.2K | $13.68K | |
YoY Change | 1524.97% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $104.3K | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $308.2K | $13.68K | |
Total Long-Term Assets | $0.00 | $104.3K | |
Total Assets | $308.2K | $118.0K | |
YoY Change | 1524.97% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.093K | ||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $182.3K | $142.3K | |
YoY Change | 185.81% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $182.3K | $142.3K | |
Total Long-Term Liabilities | |||
Total Liabilities | $182.3K | $142.3K | |
YoY Change | 185.81% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$690.9K | $151.8K | |
YoY Change | -946.8% | ||
Common Stock | $514.3K | $7.105K | |
YoY Change | 10000.82% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $435.0K | ||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $125.9K | -$24.39K | -$32.06K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $308.2K | $118.0K | |
YoY Change | 1524.97% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$539.1K | -$27.99K | -$11.50K |
YoY Change | 4121.93% | 143.38% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$509.00 | $1.619K | |
YoY Change | -131.44% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $3.485K | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $2.976K | $1.619K | |
YoY Change | 83.82% | ||
NET CHANGE | |||
Cash From Operating Activities | -$509.00 | $1.619K | |
Cash From Investing Activities | $3.485K | ||
Cash From Financing Activities | $2.976K | $1.619K | |
Net Change In Cash | |||
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$509.00 | $1.619K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001753373 | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--11-30 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2022Q1 | us-gaap |
Proceeds From Customers
ProceedsFromCustomers
|
usd | |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
usd | |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
usd | |
CY2022Q1 | us-gaap |
Development Costs
DevelopmentCosts
|
usd | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
usd | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
usd | |
CY2023Q1 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2022Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-02-28 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
333-229748 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
INKY INC. | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
36 Aigyptou Avenue | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Larnaca | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
6030 | |
CY2023Q1 | dei |
Entity Address Country
EntityAddressCountry
|
CY | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
357 | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
25057246 | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
37-1904036 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7105357 | shares |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
114 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
114 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
13567 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
13767 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
13681 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13881 | usd |
CY2023Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
104272 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
111970 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
117953 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
125851 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1093 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
476 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
65500 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
49000 | usd |
CY2023Q1 | us-gaap |
Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
|
75750 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
|
72774 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
142343 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
122250 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
142343 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
122250 | usd |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7105357 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7105357 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
7105 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7105 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
120255 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
120255 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
151750 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
123759 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24390 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-3601 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
117953 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
125851 | usd |
CY2023Q1 | us-gaap |
Proceeds From Customers
ProceedsFromCustomers
|
3400 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
3400 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
3400 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
31391 | usd |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11501 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
31391 | usd |
CY2022Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
11501 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
27991 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11501 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
27991 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
11501 | usd |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7105357 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5092023 | shares |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2021Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
5092023 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-20557 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11501 | usd |
CY2022Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
5092023 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-32058 | usd |
CY2022Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
7105357 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3601 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27991 | usd |
CY2023Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
7105357 | shares |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-24390 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
27991 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
11501 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
11183 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
200 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
325 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
16500 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
10500 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-617 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
943 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-509 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1619 | usd |
CY2023Q1 | us-gaap |
Development Costs
DevelopmentCosts
|
3485 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
3485 | usd |
CY2023Q1 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
2976 | usd |
CY2022Q1 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1619 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2976 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1619 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_847_eus-gaap--UseOfEstimates_zXy5XMz5ux9" style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; background-color: white"><b><i><span id="xdx_864_z1ka0nE9VHF3">Use of Estimates</span></i></b></p> <p style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt; background-color: white">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | |
CY2023Q1 | us-gaap |
Cash
Cash
|
114 | usd |
CY2023Q1 | us-gaap |
Shares Issued
SharesIssued
|
7105357 | shares |
CY2023Q1 | us-gaap |
Advances Fair Value Disclosure
AdvancesFairValueDisclosure
|
2976 | usd |
CY2022Q4 | us-gaap |
Advances Fair Value Disclosure
AdvancesFairValueDisclosure
|
1619 | usd |
CY2023Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
8000 | usd |
CY2022 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
8000 | usd |
CY2023Q1 | inki |
Database
Database
|
5300 | usd |
CY2022 | inki |
Database
Database
|
5300 | usd |
CY2023Q1 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
267 | usd |
CY2022 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
467 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
13567 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
13767 | usd |
CY2023Q1 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
4055 | usd |